Cargando…

Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients

The aim of this study was to investigate plasma levels and applicability of CCL2, CCR2, and tumor marker CA 15-3 in breast cancer (BC) patients and in relation to the control groups: patients with benign breast tumor and healthy subjects. Plasma levels of tested parameters were determined by enzyme-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubowicka, Emilia, Przylipiak, Andrzej, Zajkowska, Monika, Piskór, Barbara Maria, Malinowski, Paweł, Fiedorowicz, Wojciech, Ławicki, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091289/ https://www.ncbi.nlm.nih.gov/pubmed/30151375 http://dx.doi.org/10.1155/2018/2124390

Ejemplares similares

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
por: Zajkowska, Monika, et al.
Publicado: (2018)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2021)

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2016)

Matrilysins and Stromelysins in Pathogenesis and Diagnostics of Cancers
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Influence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase-12 in psoriatic patients
por: Głażewska, Edyta K., et al.
Publicado: (2017)

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis
por: Lubowicka, Emilia, et al.
Publicado: (2019)

Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2017)

Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers
por: Sidorkiewicz, Iwona, et al.
Publicado: (2019)

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis
por: Zajkowska, Monika, et al.
Publicado: (2018)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2022)

Improvements in the perception of facial attractiveness following surgical aesthetic treatment; study based on online before and after photos
por: Przylipiak, Mateusz, et al.
Publicado: (2018)

The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
por: Scheu, Stefanie, et al.
Publicado: (2017)

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
por: Yogo, Yurika, et al.
Publicado: (2009)

Targeting the CCL2-CCR2 axis in depressive disorders
por: Curzytek, Katarzyna, et al.
Publicado: (2021)

Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Functional expression of CCL8 and its interaction with chemokine receptor CCR3
por: Ge, Baosheng, et al.
Publicado: (2017)

The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
por: Rizeq, Balsam, et al.
Publicado: (2020)

Chemokine CCL7 mediates trigeminal neuropathic pain via CCR2/CCR3-ERK pathway in the trigeminal ganglion of mice
por: Zhu, Lin-Peng, et al.
Publicado: (2023)

Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain
por: Zhang, Zhi-Jun, et al.
Publicado: (2012)

Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus
por: Foresti, Maira L, et al.
Publicado: (2009)

CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
por: Falk, Mads Krüger, et al.
Publicado: (2014)

CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis
por: Nandi, Bisweswar, et al.
Publicado: (2014)

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
por: Tutunea-Fatan, Elena, et al.
Publicado: (2015)

CCL2, CCR2 Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration
por: Gudauskiene, Gaile, et al.
Publicado: (2022)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020)

Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity
por: Dansereau, Marc-André, et al.
Publicado: (2021)

Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20
por: Wasilko, David Jonathan, et al.
Publicado: (2020)

Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis
por: Bielecki, Bartosz, et al.
Publicado: (2015)

Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
por: Jørgensen, Astrid S., et al.
Publicado: (2019)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021)

Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation
por: Du, Xufei, et al.
Publicado: (2021)

CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis
por: Diaz-Rubio, Gustavo Ignacio, et al.
Publicado: (2021)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients
por: Farangis, Fatehi, et al.
Publicado: (2017)

Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation
por: Schmutz, Caroline, et al.
Publicado: (2010)

NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21
por: Witt, Robin N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uijbfiuiocrhef95ki1g64r8p2